Literature DB >> 19446472

Unraveling the genetics of complex diseases: susceptibility genes for rheumatoid arthritis and psoriasis.

Yonghong Li1, Ann B Begovich.   

Abstract

Talk of numerous genetic risk factors for rheumatoid arthritis (RA) and psoriasis has been percolating for years, but with the exception of the human leukocyte antigen (HLA) region, none have been definitively identified. Recently the results of multiple, well powered, genetic case-control studies have begun to appear providing convincing statistical evidence for at least ten non-HLA related risk genes or loci (C5/TRAF1, CD40, CTLA4, KIF5A/PIP4K2C, MMEL1/TNFRSF14, PADI4, PRKCQ, PTPN22, STAT4, and TNFAIP3/OLIG3) for RA and six (IL12B, IL13, IL23R, STAT2/IL23A, TNFAIP3, and TNIP1) for psoriasis. These initial, novel findings are beginning to shed light on the molecular pathways pertinent to the individual diseases and highlight the pleiotropic effects of several risk factors as well as the allelic heterogeneity underlying susceptibility to these and other autoimmune diseases.

Entities:  

Mesh:

Year:  2009        PMID: 19446472     DOI: 10.1016/j.smim.2009.04.002

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  20 in total

Review 1.  The Role of Pharmacogenetics in Chronic Plaque Psoriasis: Update of the Literature.

Authors:  Marina Talamonti; Simone D'Adamio; Luca Bianchi; Marco Galluzzo
Journal:  Mol Diagn Ther       Date:  2017-10       Impact factor: 4.074

2.  Carriers of rare missense variants in IFIH1 are protected from psoriasis.

Authors:  Yonghong Li; Wilson Liao; Michele Cargill; Monica Chang; Nori Matsunami; Bing-Jian Feng; Annie Poon; Kristina P Callis-Duffin; Joseph J Catanese; Anne M Bowcock; Mark F Leppert; Pui-Yan Kwok; Gerald G Krueger; Ann B Begovich
Journal:  J Invest Dermatol       Date:  2010-07-29       Impact factor: 8.551

3.  Peripheral blood gene expression patterns discriminate among chronic inflammatory diseases and healthy controls and identify novel targets.

Authors:  Bertalan Mesko; Szilard Poliska; Andrea Szegedi; Zoltan Szekanecz; Karoly Palatka; Maria Papp; Laszlo Nagy
Journal:  BMC Med Genomics       Date:  2010-05-05       Impact factor: 3.063

4.  A haplotype at STAT2 Introgressed from neanderthals and serves as a candidate of positive selection in Papua New Guinea.

Authors:  Fernando L Mendez; Joseph C Watkins; Michael F Hammer
Journal:  Am J Hum Genet       Date:  2012-08-10       Impact factor: 11.025

5.  Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus.

Authors:  Deborah S Cunninghame Graham; David L Morris; Tushar R Bhangale; Lindsey A Criswell; Ann-Christine Syvänen; Lars Rönnblom; Timothy W Behrens; Robert R Graham; Timothy J Vyse
Journal:  PLoS Genet       Date:  2011-10-27       Impact factor: 5.917

6.  Pediatric psoriasis: an update.

Authors:  Nanette B Silverberg
Journal:  Ther Clin Risk Manag       Date:  2009-11-02       Impact factor: 2.423

7.  Identification of TNIP1 Polymorphisms by High Resolution Melting Analysis with Unlabelled Probe: Association with Systemic Lupus Erythematosus.

Authors:  Jie Zhang; Yuewen Chen; Yong Shao; Qi Wu; Ming Guan; Wei Zhang; Jun Wan; Bo Yu
Journal:  Autoimmune Dis       Date:  2012-07-19

8.  Meta-analysis of 125 rheumatoid arthritis-related single nucleotide polymorphisms studied in the past two decades.

Authors:  Yongshuai Jiang; Ruijie Zhang; Jiajia Zheng; Panpan Liu; Guoping Tang; Hongchao Lv; Lanying Zhang; Zhenwei Shang; Yuanbo Zhan; Wenhua Lv; Miao Shi; Ruimin Zhang
Journal:  PLoS One       Date:  2012-12-10       Impact factor: 3.240

Review 9.  Genetics of psoriasis and pharmacogenetics of biological drugs.

Authors:  Rocío Prieto-Pérez; Teresa Cabaleiro; Esteban Daudén; Dolores Ochoa; Manuel Roman; Francisco Abad-Santos
Journal:  Autoimmune Dis       Date:  2013-08-28

Review 10.  Management of psoriasis in adolescence.

Authors:  Christina Fotiadou; Elizabeth Lazaridou; Demetrios Ioannides
Journal:  Adolesc Health Med Ther       Date:  2014-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.